As someone who has spent significant time researching and experimenting with various research compounds, I have learned that the delivery method is just as critical as the quality of the substance ...

“We want to make sure we are not producing a financial burden for patients in exchange for that convenience [with subcutaneous therapies],” said J. Thaddeus Beck, MD, FACP. A growing number of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Share on Pinterest Research shows that certain types of birth control, particularly those high in progestogen, may raise the risk of brain tumors. Image Credit: Pekic/Getty A new study revealed a link ...

Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming that it was ...

U.S. District Judge M. Casey Rodgers, in the Northern District of Florida, postponed her expert ruling this month due to a settlement reached between Pfizer and lead counsel in the Depo-Provera ...

When Lindsey Boynton was offered the option to give herself her birth control shot at home, she was surprised the option even existed. The method — self-injected subcutaneous depot medroxyprogesterone ...

The plaintiffs bar has argued that courts can only preempt prescription pharmaceutical state law failure-to-warn claims when the FDA formally rejects a proposed label change. Faced with that exact ...

Self-administered injectable contraception has been available in the U.S. for more than two decades, yet a new study found that only about a quarter of reproductive health experts prescribe it — and ...

DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.

PENSACOLA, Fla.--(BUSINESS WIRE)--At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...